Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Unlike many compounds that target a single pathway, BPC-157 activates multiple interconnected repair mechanisms simultaneously
Thymosin Beta-4 Heritage: Parent compound is endogenous and well-characterized Clinical Trials: RegeneRx trials showed generally favorable safety in ophthalmic and cardiac applications Cancer Concerns: Theoretical concerns about cell migration and tumor potential
Kent Holtorf, Integrative Peptides emerged from a simple observation
The safety findings were more informative than the efficacy data
doi:10.1073/pnas.0308082100
After surgery in rats, it raised the pain threshold early on, but the effect was gone within about a week
US$ 24.64
US$ 23.35
US$ 24.22
US$ 20.60
US$ 21.33
US$ 22.88
US$ 28.10
US$ 23.40
US$ 26.06
